Skip to main content
. 2016 Aug;5(2):150–160. doi: 10.15420/AER.2016.19.2

Table 2: Overview of Recent Literature Concerning Atrial Tachycardia Ablation in Paients with Repaired Congenital Heart Disease.

Author, Year Location Year of Inclusion CHD Type (n) Method Imaging Patients (n) AT, no AT, mean cl AT type (n) Acute Success (%) Definition Endpoint Recurrence After Any (Successfull) Ablation (%) Mean FU Time (Months)
Correa, 2015 Boston, US 2006–12 Fontan (52) Extracard. (4) Intracard. (48) AM ICE 52 80 312 CTIDF(14) IART (11) FAT (8) Other (21) CTIDF (100) IART (81) FAT (100) All (84) TDA + Nl 50(16) 18
correa, 2013 Boston, US 2006–10 Fontan Classic (52) Modern (37) TGA Mustard (16) Senning(l3) NP 90 170 NP IART (78) FAT (22) other (70) 81 Nl and/or DB (not specified) 30 (NP) 12
ueda, 2013 London, UK 2007–12 ASD, Ebstein, Fontan, Mustard, TOF, VSD AM,LL CMR 116 228 NP CTIDF (47) IART (87) FAT (43) Other (51) 86 Nl 21 (NP) 20
Akca, 2012 Rotterdam, the Netherlands 2007–11 AOS(1), ASD (4) AVSD (2), Ebstein (6), PD(1), PS (2), ?? (4), TGA (10), TOF (3), VSD (3) RMN,Af 36 59 NP CTIDF (5) IART (19) FAT (13) 86 IART (81) FAT (88) Nl 19 redo 39 (NP) 26
Mah, 2011 Boston, US 1997–2010 TOF (59) AM, SM 95 127 303 (IART) CTIDF (50) IART (45) FAT (13) EAT (4) CTIDF (94) IART (84) FAT (92) EAT (100) TDA in all + Nl in 32 IART/CTIDF/FAT + DB in 34 CTIDF/I ART/FAT 34 (NP) NP
De Groot, 2010
Leiden, the Netherlands 2000–04 ASD (11), COA(2), Ebstein (1), Fontan (14), TGA (4), TOF (10), Valvular (9), VSD (2) AM, SM 53 54 288 (IDAF) 309 (IART) 380 (FAT) CTIDF (27) IART (22) FAT (5) 66 IART (55) FAT (100) CTIDF: DB IART/FAT: TDA 55 (NP) 60
Yap, 2010 Toronto, Canada 1993–2009 ASD (21), AVSD (9), Fontan (21), Other (14), TGA(21), TOF(18), VSD (5) AM, SM, LL 130 118 NP IART 63 TDA, Nl 57 (48) 40
WU, 2010 Munich, Germany 2006–08 ASD (2), EbSteind), Fontan (9), Mustard (2), Senning(4) RMN.AM 22 26 321 CTIDF (8) IART (14) FAT (2) 95 TDA (TGA) Nl (Fontan) DB (simple CHD) 9(NP) 8
Peichl, 2009 Prague, Czech Republic 2004–07 (cc)TGA (4), Fontan (3)VSD(1) AM, SM ICE 7 12 320 CTIDF(4) IART (6) FAT (2) 100 DB (CTIDF) 28 (NP) 23
Uew, 2008 London, U < 2002–07 APV(1), ASD (9), TGA(1), TOF(1) AM, SM 12 12 NP CTIDF (1) IART (9) FAT(1) Other (1) 88 TDA, Nl DB (Linear lesions) 33 (36) 26
Triedman, 2005 Boston, us 3 2002–03 Fontan (9) other biventricular (20) SM 27 67 312 CTIDF (27) IART (40) 66 TDA+ Nl + DB 19 (NP) 6

AT = atrial tachycardia; AM = activation mapping; AoS = aortic stenosis; APV = anomalous pulmonary vein drainage; ASD = atrial septal defect; AVSD = atrioventricular septal defect; CHD = congenital heart disease; CMR = cardiac magnetic resonance imaging; CoA = coarctation of the aorta; (cc)TGA = (congenitally corrected) transposition of the great arteries; CTIDF = cavotricuspid isthmus dependent flutter; CTI = cavotricuspid isthmus; DB = demonstrated bidirectional conduction block along the ablation line; EAT = ectopic atrial tachycardia; EM = entrainment mapping; FAT = focal atrial tachycardia; FU = follow-up; IART = intra-atrial reentrant tachycardia; ICE = intra-cardiac echography; IMG = image integration; LL = linear lesions; NI = non-inducibility after ablation; NP = data not provided; PD = patent ductus; PS = pulmonary stenosis; RMN = remote magnetic navigation; SM = substrate mapping; TA = tricuspid atresia; TDA = termination during ablation; TOF = tetralogy of Fallot; VSD = ventricular septal defect.